venBio Global Strategic Fund IV, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001862109. 10% Owner at Attovia Therapeutics, Inc. (ATTO). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in SAN FRANCISCO, CA.
Companies venBio Global Strategic Fund IV, L.P. has filed insider reports for
- Attovia Therapeutics, Inc. (ATTO): 10% Owner
venBio Global Strategic Fund IV, L.P.
CIK: 0001862109
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (75.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATTO
Attovia Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionDirect2.3M shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionDirect822K shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionDirect665.1K shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
PurchaseDirect382.4K shares at avg. $17.00$6.5M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 2,311,870 | - | $0 | Direct |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 821,998 | - | $0 | Direct |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 665,147 | - | $0 | Direct |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Purchase | 382,352 | $17.00 | $6,499,984 | Direct |
1-4 of 4 transactions